Anti-allergic drug use in Japan-the rationale and the clinical outcome
- 1 April 1994
- journal article
- review article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 24 (4) , 299-306
- https://doi.org/10.1111/j.1365-2222.1994.tb00239.x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Mast Cell Mediators and AsthmaPublished by S. Karger AG ,2015
- Upregulation of formyl-peptide and interleukin-8—induced eosinophil chemotaxis in patients with allergic asthmaJournal of Allergy and Clinical Immunology, 1993
- The effect of azelastine on neutrophil and eosinophil generation of superoxideJournal of Allergy and Clinical Immunology, 1989
- Antiallergic effects of mequitazine. 1. In vitro experiments.Folia Pharmacologica Japonica, 1988
- Inhibitory Effects of Oxatomide on Intracellular Ca Mobilization, Ca Uptake and Histamine Release, Using Rat Peritoneal Mast CellsInternational Archives of Allergy and Immunology, 1987
- Antagonistic effect of KC-404, a new anti-asthmatic agent, on leukotriene D4-induced contractile responses in isolated guinea pig smooth musclesProstaglandins, 1986
- The mast cell as a primary effector cell in the pathegenesis of asthmaJournal of Allergy and Clinical Immunology, 1986
- The Antiallergic Agent Amoxanox Suppresses SRS-A Generation by Inhibiting LipoxygenaseInternational Archives of Allergy and Immunology, 1986
- PHARMACOLOGICAL PROPERTIES OF N‐(3′,4′‐DIMETHOXYCINNAMOYL) ANTHRANILIC ACID (N‐5′), A NEW ANTI‐ATOPIC AGENTBritish Journal of Pharmacology, 1976
- Inhibition of hypersensitivity reactions by a new drug, N(3′,4′-dimethoxycinnamoyl) anthranilic acid (N-5′)Journal of Allergy and Clinical Immunology, 1976